We present a case report of a patient with a suspicious ileal carcinoid tumour. Clinical examination as well as computer tomograghy (CT) scan suggested a tumour. Octeotride scan showed uptake in the same bowel loop re...We present a case report of a patient with a suspicious ileal carcinoid tumour. Clinical examination as well as computer tomograghy (CT) scan suggested a tumour. Octeotride scan showed uptake in the same bowel loop reported as pathological in CT. The patient underwent surgery and biopsy which reported Crohn’s disease (CD). The interest in the case is due to the fact that this is, to the best of our knowledge, the second report of Crohn’sdisease as a cause of false positive octeotride scan. Unfortunately, no somatostatin recptors could be found in the sample, so further studies should be performed.展开更多
Retinoic acid receptor-α (RAR α) plays a major role in the growth inhibitory effect of retinoic acid on human breast cancer cells, may be it could serve as an indicator to guide the treatment and prevent of breast c...Retinoic acid receptor-α (RAR α) plays a major role in the growth inhibitory effect of retinoic acid on human breast cancer cells, may be it could serve as an indicator to guide the treatment and prevent of breast cancer with retinoic acid in clinic. All previous researchs were based on observing the changes of RAR α mRAN expression. In this study, the expression of RAR α in human breast cell lines was studied by Northern Blot, Western Blot and Immunohistochemistry in mRNA level and protein level. Results showed that RAR α protein expression was correlated with RAR α mRNA expression. RAR α mRNA ex- pression was higher in estrogen receptor (ER)-positive human breast cancer cell lines than in ER-negative ones. So was RAR a protein expression. Both RAR α mRNA amd RAR α protein expression were associ- ated with ER status. The expression of RAR α and the relationship between RAR a and ER status were al- so determined by immunohistochemistry in 58 human primary breast cancer tumors. 37 (63. 8% ) tumors were ER-positive and of these 28 (75. 7% ) were also RAR α -positive. The coexpression of ER and RAR a was statistically significant (P＜0. 01, by X^2 contingency analysis). It was reported that RAR α expres- sion in cultured breast cancer cells was regulated by estrogen acting via the ER. Our study demonstrated that RAR α expression may be modulated in breast cancer in vivo by estrogen via ER.展开更多
文摘We present a case report of a patient with a suspicious ileal carcinoid tumour. Clinical examination as well as computer tomograghy (CT) scan suggested a tumour. Octeotride scan showed uptake in the same bowel loop reported as pathological in CT. The patient underwent surgery and biopsy which reported Crohn’s disease (CD). The interest in the case is due to the fact that this is, to the best of our knowledge, the second report of Crohn’sdisease as a cause of false positive octeotride scan. Unfortunately, no somatostatin recptors could be found in the sample, so further studies should be performed.
文摘Retinoic acid receptor-α (RAR α) plays a major role in the growth inhibitory effect of retinoic acid on human breast cancer cells, may be it could serve as an indicator to guide the treatment and prevent of breast cancer with retinoic acid in clinic. All previous researchs were based on observing the changes of RAR α mRAN expression. In this study, the expression of RAR α in human breast cell lines was studied by Northern Blot, Western Blot and Immunohistochemistry in mRNA level and protein level. Results showed that RAR α protein expression was correlated with RAR α mRNA expression. RAR α mRNA ex- pression was higher in estrogen receptor (ER)-positive human breast cancer cell lines than in ER-negative ones. So was RAR a protein expression. Both RAR α mRNA amd RAR α protein expression were associ- ated with ER status. The expression of RAR α and the relationship between RAR a and ER status were al- so determined by immunohistochemistry in 58 human primary breast cancer tumors. 37 (63. 8% ) tumors were ER-positive and of these 28 (75. 7% ) were also RAR α -positive. The coexpression of ER and RAR a was statistically significant (P＜0. 01, by X^2 contingency analysis). It was reported that RAR α expres- sion in cultured breast cancer cells was regulated by estrogen acting via the ER. Our study demonstrated that RAR α expression may be modulated in breast cancer in vivo by estrogen via ER.
